Related Experiment Videos
Effects of the immunomodulator linomide on macrophage migration and myelin phagocytic activity in peripheral nerve
V I Vougioukas1, H Siebert, K Heinecke
1Department of Neuropathology, Charité, Berlin, Germany.
Abstract:
Wallerian degeneration after peripheral nerve transection leads to the phagocytosis of degenerated myelin and axon components by macrophages. These phagocytes are recruited from the systemic circulation and Wallerian degeneration may therefore be used as a model for myelin removal by hematogenous macrophages, a feature that is also a hallmark of demyelinating diseases of the central and peripheral nervous system. The immunomodulator linomide has been shown to be effective in the treatment of experimental demyelinating diseases although the exact mode of its action is not yet defined. The present study investigated the effect of linomide on monocyte invasion and myelin phagocytosis after sciatic nerve transection. Linomide had a dual effect in Wallerian degeneration. Monocyte migration from the circulation to the damaged nervous system was significantly reduced. Additionally, the myelin phagocytic capacity of macrophages was impaired, finally resulting in a significant delay in the removal of myelin. The present experiments may provide an explanation for the effects of linomide during the course of demyelinating diseases of the nervous system.
Insights
Linomide impairs macrophage function during Wallerian degeneration, reducing monocyte invasion and myelin phagocytosis. This delay in myelin removal may explain linomide
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Wallerian degeneration involves macrophage phagocytosis of nerve debris.
- Hematogenous macrophages clear myelin in Wallerian degeneration and demyelinating diseases.
- Linomide is an immunomodulator used for experimental demyelinating diseases.
Purpose of the Study:
- To investigate linomide's effect on monocyte invasion and myelin phagocytosis.
- To understand linomide's mechanism in Wallerian degeneration.
- To correlate findings with linomide's efficacy in demyelinating diseases.
Main Methods:
- Sciatic nerve transection model in rodents.
- Administration of linomide.
- Assessment of monocyte migration and myelin phagocytosis by macrophages.
Main Results:
- Linomide significantly reduced monocyte migration to the damaged nerve.
- Linomide impaired the myelin phagocytic capacity of macrophages.
- Myelin removal was significantly delayed following linomide treatment.
Conclusions:
- Linomide exerts a dual inhibitory effect on Wallerian degeneration.
- Linomide's impact on macrophage function may explain its therapeutic effects in demyelinating conditions.
- Further research into linomide's immunomodulatory mechanisms is warranted.